Jerome Hogge bought $301K of Claritev (CTEV)
Executed Aug 7 2025, disclosed Aug 11 2025, 4 days later.
Over the 21 trading sessions from the disclosed entry session (Aug 11 2025), the stock returned +25.9% (delay-adjusted); from the execution session (Aug 7 2025), +36.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
Jerome Hogge (EVP, Chief Operating Officer) filed 2 Form 4 reports in the past 24 months (2 purchases, 0 sales), most often in Claritev Corporation (CTEV). Across 2 priced purchase filings, the average 21-session return was +42.5% from execution and +37.1% from disclosure (delay-adjusted; derived). The largest single filing was $349K of CTEV (12,500 sh × $27.94, as filed), executed May 19 2025.
Healthcare · Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, a…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→12,500 sh × $27.94
Exec May 19 2025
Filed May 20 2025 · 5:30 PM ET